Ironwood Pharmaceuticals | IRWD - Ativos





Ativos Alterar Data
Acadia Pharmaceuticals USD 1.61B 41.04M 2026-03
Agios Pharmaceuticals USD 1.18B 112.24M 2026-03
Akebia Therapeutics USD 362.52M 14.04M 2026-03
Almirall EUR 2.34B 29.21M 2025-12
Alnylam Pharmaceuticals USD 5.13B 163.22M 2026-03
Amarin USD 645.76M 25.01M 2026-03
Ardelyx USD 504.51M 2.9M 2026-03
Astellas Pharma JPY 3.57T 36.87B 2026-03
AstraZeneca USD 114.02B 59M 2026-03
Charles River Laboratories USD 7.73B 594.89M 2026-03
Coherus Biosciences USD 258.34M 258.18M 2025-12
Emergent BioSolutions USD 1.82B 69.9M 2023-12
Esperion Therapeutics USD 462.53M 3.36M 2026-03
Halozyme Therapeutics USD 2.67B 147.4M 2026-03
Incyte USD 7.34B 381.14M 2026-03
Ironwood Pharmaceuticals USD 434.57M 37.66M 2026-03
Karyopharm Therapeutics USD 108.42M 12.18M 2025-12
Lexicon Pharmaceuticals USD 268.82M 83.83M 2026-03
MacroGenics USD 217.87M 38.97M 2026-03
Moderna USD 11.49B 850M 2026-03
Myriad Genetics USD 673.7M 32.9M 2026-03
Pacira USD 1.21B 56.38M 2026-03
PTC Therapeutics USD 2.87B 29.66M 2026-03
Puma Biotechnology USD 202.86M 7.95M 2025-09
Sarepta Therapeutics USD 3.18B 170.77M 2026-03
Takeda JPY 15.45T 44.34B 2026-03
Ultragenyx Pharmaceutical USD 1.3B 236M 2026-03
Vanda Pharmaceuticals USD 488.95M 112.19M 2025-12